Search results for "Multiple sclerosis"

showing 10 items of 630 documents

Cardiovascular comorbidity in multiple sclerosis patients treated with mitoxantrone therapy: a cohort study

2017

Abstract Background Mitoxantrone (MX) has been used as second line therapy for aggressive multiple sclerosis (MS). Potential cardiotoxic effects of MX limit its use; a cumulative dose of up to 100 mg/m2, has been long considered relatively safe. We calculated the frequency of cardiac side effects in MS patients treated with MX. Methods We performed a cohort study including all MS patients treated with MX at the Neurological Department of the University Hospital of Palermo, Italy. Two hundred-sixty-four MS patients diagnosed according to validated criteria were included and followed-up until the end of September 2010. Patients were treated with MX as a second line therapy if they had no prev…

medicine.medical_specialtyImmunologyHeart failureComorbidity030204 cardiovascular system & hematologylcsh:RC346-429Multiple sclerosis03 medical and health sciences0302 clinical medicineInternal medicinemedicineImmunology and AllergyMyocardial infarctionlcsh:Neurology. Diseases of the nervous systemMitoxantroneEjection fractionmedicine.diagnostic_testCumulative dosebusiness.industryComorbidity Multiple sclerosis Heart failure Mitoxantrone Therapymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareNeurologyHeart failureCohortPhysical therapySettore MED/26 - NeurologiaTherapyNeurology (clinical)MitoxantronebusinessElectrocardiography030217 neurology & neurosurgeryCohort studymedicine.drug
researchProduct

Perturbed Glucose Metabolism: Insights into Multiple Sclerosis Pathogenesis

2014

Multiple sclerosis (MS) is a complex debilitating disease of the central nervous system perceived to result from the autoimmune effect of T cells in damaging myelin sheath. However, the exact pathogenesis of the disease remains elusive. Initial studies describing the possibility of defective pyruvate metabolism in MS were performed in 1950s. The group observed elevated blood pyruvate level in both fasting and postprandial times in MS patients with relapse. Similarly, other investigators also reported increased fasting pyruvate level in this disease. These reports hint to a possible abnormality of pyruvate metabolism in MS patients. In addition, increase in levels of Krebs cycle acids like a…

medicine.medical_specialtyMini ReviewCentral nervous systemDiseaseCarbohydrate metabolismBioinformaticsmultiple sclerosislcsh:RC346-429PathogenesisInternal medicinebrain glucose metabolismmedicineneurodegenerative diseaseslcsh:Neurology. Diseases of the nervous systemmitochondrial defectsbusiness.industryMultiple sclerosisand neurodegenerative diseasesmedicine.diseasecell-specific mechanismsReview articleCitric acid cycleMetabolic pathwaymedicine.anatomical_structureEndocrinologyNeurologyNeurology (clinical)businessNeuroscienceFrontiers in Neurology
researchProduct

Answer to: The possible risk of cancer in multiple sclerosis patients: a controversial issue

2010

medicine.medical_specialtyMultiple Sclerosis | Demyelinating Diseases | concentric sclerosisNeurologybusiness.industryMultiple sclerosisPhysical therapyMedicineCancerSettore MED/26 - NeurologiaNeurology (clinical)businessIntensive care medicinemedicine.diseaseEuropean Journal of Neurology
researchProduct

Link of the mechanisms of action of glatiramer acetate to its long-term clinical data

2009

A consequence of the long-term nature of progression in multiple sclerosis is that treatment needs to be provided over the long term. Gathering evidence for long term clinical efficacy, safety and patient acceptance of immunomodulatory therapies is thus a critically important issue. However, pivotal trials, which generally last no more than two years, cannot address this issue. Glatiramer acetate is the only immunomodulatory treatment for which prospective data is available covering a treatment period of over a decade. In the long-term extension of the pivotal trial of glatiramer acetate, 108 patients have been followed for a mean treatment duration of 10.1 years. At the end of the treatmen…

medicine.medical_specialtyMultiple SclerosisTimeSecondary PreventionHumansMedicineClinical efficacyGlatiramer acetateIntensive care medicineClinical Trials as Topicbusiness.industryMultiple sclerosisGlatiramer AcetatePrognosismedicine.diseaseTreatment periodTerm (time)Clinical trialTreatment OutcomeNeurologyAmbulatoryDisease ProgressionPhysical therapyObservational studyNeurology (clinical)PeptidesbusinessRisk Reduction BehaviorImmunosuppressive Agentsmedicine.drugJournal of the Neurological Sciences
researchProduct

Design and Validation of an Expanded Disability Status Scale Model in Multiple Sclerosis.

2020

<b><i>Introduction:</i></b> We aimed to develop and validate an Expanded Disability Status Scale (EDSS) model through clinical, optical coherence tomography (OCT), and magnetic resonance imaging (MRI) measures. <b><i>Methods:</i></b> Sixty-four multiple sclerosis (MS) patients underwent peripapillary retinal nerve fiber layer and segmented macular layers evaluation through OCT (Spectralis, Heidelberg Engineering). Brain parenchymal fraction was quantified through Freesurfer, while cervical spinal cord (SC) volume was assessed manually guided by Spinal Cord Toolbox software analysis. EDSS, neuroradiological, and OCT assessment were carried out …

medicine.medical_specialtyMultiple Sclerosisgenetic structuresPhysics::Medical PhysicsNerve fiber layerOrdinal regressionRetinaExpanded disability status scale Magnetic resonance imaging Multiple sclerosis Spectral domain optical coherence tomography Spinal cordDisability EvaluationOptical coherence tomographyOphthalmologyHumansMedicineCutoffExpanded Disability Status Scalemedicine.diagnostic_testbusiness.industryMultiple sclerosisBrainMagnetic resonance imagingmedicine.diseaseSpinal cordMagnetic Resonance Imagingeye diseasesmedicine.anatomical_structureNeurologyNeurology (clinical)sense organsbusinessTomography Optical Coherence
researchProduct

Effectiveness of technology-based distance physical rehabilitation interventions on physical activity and walking in multiple sclerosis: a systematic…

2016

Objective: To determine the effectiveness of technology-based distance physical rehabilitation interventions in multiple sclerosis (MS) on physical activity and walking. Data sources: A systematic literature search was conducted in seven databases from January 2000 to September 2016. Randomized controlled trials of technology-based distance physical rehabilitation interventions on physical activity and walking outcome measures were included. Methods: Methodological quality of the studies was determined and a meta-analysis was performed. In addition, a subanalysis of technologies and an additional analysis comparing to no treatment were conducted. Results: The meta-analysis consisted of 11 s…

medicine.medical_specialtyMultiple SclerosishyvinvointiteknologiaPsychological interventionPhysical activityphysical activitydistance physical rehabilitationWalkingMean differencelaw.inventionwalking03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationsystematic reviewRandomized controlled trialMS-tautilawmedicineHumans030212 general & internal medicineMethodological qualityExerciseRandomized Controlled Trials as TopicTelerehabilitationbusiness.industryMultiple sclerosisRehabilitationOutcome measuresmedicine.diseaserehabilitation technologyMeta-analysisPhysical therapykuntoutusbusinessfyysinen aktiivisuus030217 neurology & neurosurgeryDisability and Rehabilitation
researchProduct

A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia

2021

The prevalence of trigeminal neuralgia (TN) in patients with Multiple Sclerosis (MS) is higher than in the general population and its management can be particularly challenging due to a number of reasons including high recurrence rates, lack of MS-specific treatment guidelines and uncertainties about pain pathophysiology. Aim of this cross-sectional, multicentre survey was to gather information on the current treatment modalities and options of MS-related TN across 23 Italian MS centres. Initial medical management (carbamazepine or oxcarbazepine) of MS-related TN was fairly homogeneous throughout Italian centres. The most commonly available surgical procedure was microvascular decompression…

medicine.medical_specialtyMultiple Sclerosismultiple sclerosis; trigeminal neuralgiaCross-sectional studymedicine.medical_treatmentPopulationMicrovascular decompressionHealth Services Accessibility03 medical and health sciences0302 clinical medicineRetrospective StudieTrigeminal neuralgiaMultiple SclerosimedicineHumans030212 general & internal medicineIntensive care medicineeducationOxcarbazepineRetrospective StudiesCross-Sectional Studieeducation.field_of_studybusiness.industryMultiple sclerosisRetrospective cohort studyTrigeminal Neuralgiamedicine.diseaseCross-Sectional StudiesTreatment OutcomeItalyNeurologyMulticenter surveyNeurology (clinical)businessMultiple Sclerosis; Trigeminal neuralgia; Cross-Sectional Studies; Health Services Accessibility; Humans; Italy; Retrospective Studies; Treatment Outcome; Multiple Sclerosis; Trigeminal NeuralgiaTrigeminal neuralgia030217 neurology & neurosurgeryHumanmedicine.drugJournal of the Neurological Sciences
researchProduct

Effects of physiotherapy interventions on balance in multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials

2012

Objective: to determine the effects of physiotherapy inter ­ ventions on balance in people with multiple sclerosis. Data sources: A systematic literature search was conducted in Medline, cinahl, embase, PeDro, both electronically and by manual search up to March 2011. Study selection: Randomized controlled trials of physiothe­ rapy interventions in people with multiple sclerosis, with an outcome measure linked to the International Classifica­ tion of Functioning, Disability and Health (icF) category of “changing and maintaining body position”, were included. Data extraction: the quality of studies was determined by the van tulder criteria. Meta­analyses were performed in subgroups according…

medicine.medical_specialtyMultiple SclerosistasapainoPsychological interventionMEDLINEPhysical Therapy Sports Therapy and RehabilitationCINAHLfysioterapialaw.inventionPhysical medicine and rehabilitationsystematic reviewRandomized controlled trialMS-tautilawmedicineHumansExercisePostural BalancePhysical Therapy ModalitiesRandomized Controlled Trials as TopicBalance (ability)business.industryMultiple sclerosisRehabilitationResistance TrainingGeneral Medicinemedicine.diseaseTreatment OutcomeData extractionMeta-analysisSensation DisordersPhysical therapybusinessexercise trainingJournal of Rehabilitation Medicine
researchProduct

Vertigo and multiple sclerosis: aspects of differential diagnosis.

2002

Equilibrium disorders caused by involvement of brainstem and cerebellar structures are common in patients with multiple sclerosis (MS), but peripheral conditions such as benign paroxysmal positional vertigo (BPPV) can be sometimes confused with those of a central origin. Therefore, an accurate otoneurologic investigation paying attention to differential diagnosis aspects should be performed in these subjects. Among available diagnostic tools, electro-oculography, posturography and vestibular evoked myogenic potentials (VEMPs) are especially suited to assess vestibulo-oculomotor and vestibulospinal systems. This paper briefly describes the most recent otoneurologic diagnostic strategies for …

medicine.medical_specialtyNeurologyBenign paroxysmal positional vertigoMultiple SclerosisVestibular evoked myogenic potentialDiagnostic Techniques NeurologicalDermatologyAudiologyDiagnosis DifferentialVertigootorhinolaryngologic diseasesmedicineEvoked Potentials Auditory Brain StemHumansNeuroradiologyDiagnostic Techniques Otologicalbiologybusiness.industryElectromyographyMultiple sclerosisPosturographyGeneral Medicinebiology.organism_classificationmedicine.diseasePsychiatry and Mental healthVertigoAtaxiasense organsNeurology (clinical)Differential diagnosisbusinessNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

Transcranial magnetic resonance-guided focused ultrasound thalamotomy as a safe treatment option in multiple sclerosis patients with essential tremor

2020

Transcranial magnetic resonance-guided focused ultrasound is a recently introduced incisionless treating option for essential tremor and tremor-dominant idiopathic Parkinson disease. There is preliminary evidence that it may result in a promising effective treatment option for other movement disorders too. Here, we report on two patients with multiple sclerosis with medication refractory debilitating essential tremor comorbidity who successfully underwent unilateral Vim tcMRgFUS thalamotomy for tremor control. Patients' clinical condition and expanded disability status scale scores showed no changes during the 1-year follow-up period with no evidence of multiple sclerosis activity or progre…

medicine.medical_specialtyNeurologyMovement disordersMagnetic Resonance SpectroscopyMultiple Sclerosismedicine.medical_treatmentEssential TremorDermatologyStereotaxic Techniques03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationThalamusMultiple SclerosimedicineHumansInterventional Magnetic Resonance Imaging030212 general & internal medicineExpanded Disability Status Scalemedicine.diagnostic_testEssential tremorThalamotomybusiness.industrySettore MED/27 - NeurochirurgiaMultiple sclerosisSettore MED/37 - NeuroradiologiaMagnetic resonance imagingGeneral Medicinemedicine.diseaseMagnetic Resonance Imagingnervous system diseasesPsychiatry and Mental healthTreatment OutcomeStereotaxic techniqueHigh-Intensity Focused Ultrasound AblationSettore MED/26 - NeurologiaNeurology (clinical)medicine.symptombusinessSettore MED/36 - Diagnostica Per Immagini E Radioterapia030217 neurology & neurosurgery
researchProduct